ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lilly and KeyBioscience collaborate to develop potential type 2 diabetes treatment
June 13, 2017US-based Eli Lilly and Company has collaborated with Nordic Bioscience subsidiary KeyBioscience to develop Dual Amylin Calcitonin Receptor Agonists (DACRAs), a potential new class of treatments for patients with metabolic disorders such as type 2 diabetes
Pharma Sources Insight January 2025
